メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
並べ替え順
Keyphrases
Clinical Features
100%
Type 2 Diabetic Patients
100%
Hemoglobin A1c (HbA1c)
100%
Oral Antidiabetic Drugs
100%
Drug Feature
100%
Sulfonylurea
57%
Dipeptidyl peptidase-4 (DPP-4)
42%
Japan
28%
Metformin
28%
Type 2 Diabetic
14%
Propensity Score
14%
Age of Onset
14%
Body Mass Index
14%
Glycemic Control
14%
Nave
14%
Management Research
14%
Baseline Factors
14%
Observational Cohort Study
14%
Original Drug
14%
Diabetes Data Management
14%
Medicine and Dentistry
Diabetes Mellitus
100%
Clinical Feature
100%
Hemoglobin A1c
100%
Oral Antidiabetic Agent
100%
Sulfonylurea
57%
Dipeptidyl Peptidase-4 Inhibitor
42%
Glycon
28%
Onset Age
14%
Body Mass Index
14%
Diabetes
14%
Glycemic Control
14%
Cohort Studies
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
100%
Diabetes Mellitus
100%
Hemoglobin A1c
100%
Oral Antidiabetic Agent
100%
Sulfonylurea
57%
Dipeptidyl Peptidase IV Inhibitor
42%
Metformin
28%
Cohort Study
14%
Onset Age
14%
Neuroscience
Diabetes Mellitus
100%
Hemoglobin A1c
100%
Sulfonylurea
57%
Dipeptidyl Peptidase-4 Inhibitor
42%
Metformin
28%
Body Mass Index
14%